Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence B Snyder

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Electrostatic interaction of pi-acidic amides with hydrogen-bond acceptorsYi Li, Lawrence B Snyder, David R Langley
Annual Reports in Medicinal Chemistry|April 15, 2020
Chapter 22. Non-HIV antiviral agentsNicholas A Meanwell, Michael H Serrano-Wu, Lawrence B Snyder
Bioorganic & Medicinal Chemistry Letters|March 6, 2003
Discovery of the first antibacterial small molecule inhibitors of MurBJoanne J Bronson, Kenneth L DenBleyker, Paul J Falk, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 31, 2015
Identification of glutathione conjugates of acetylene-containing positive allosteric modulators of metabotropic glutamate receptor subtype 5Xiaoliang Zhuo, Xiaohua Stella Huang, Andrew P Degnan, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2004
Discovery of isoxazolinone antibacterial agents. Nitrogen as a replacement for the stereogenic center found in oxazolidinone antibacterialsLawrence B Snyder, Zhaoxing Meng, Robert Mate, et al.
Journal of Virology|October 9, 2009
Identification of hepatitis C virus NS5A inhibitorsJulie A Lemm, Donald O'Boyle, Mengping Liu, et al.
The Journal of General Virology|July 29, 2011
The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localizationDike Qiu, Julie A Lemm, Donald R O'Boyle, et al.
Molecular Cancer Therapeutics|December 13, 2024
Preclinical Evaluation of Bavdegalutamide (ARV-110), a Novel PROteolysis TArgeting Chimera Androgen Receptor DegraderLawrence B Snyder, Taavi K Neklesa, Ryan R Willard, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2011
Discovery of potent hepatitis C virus NS5A inhibitors with dimeric structuresJulie A Lemm, John E Leet, Donald R O'Boyle, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical StilbenesJeffrey L Romine, Denis R St Laurent, John E Leet, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Electrostatic interaction of pi-acidic amides with hydrogen-bond acceptorsYi Li, Lawrence B Snyder, David R Langley
Annual Reports in Medicinal Chemistry|April 15, 2020
Chapter 22. Non-HIV antiviral agentsNicholas A Meanwell, Michael H Serrano-Wu, Lawrence B Snyder
Bioorganic & Medicinal Chemistry Letters|March 6, 2003
Discovery of the first antibacterial small molecule inhibitors of MurBJoanne J Bronson, Kenneth L DenBleyker, Paul J Falk, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 31, 2015
Identification of glutathione conjugates of acetylene-containing positive allosteric modulators of metabotropic glutamate receptor subtype 5Xiaoliang Zhuo, Xiaohua Stella Huang, Andrew P Degnan, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2004
Discovery of isoxazolinone antibacterial agents. Nitrogen as a replacement for the stereogenic center found in oxazolidinone antibacterialsLawrence B Snyder, Zhaoxing Meng, Robert Mate, et al.
Journal of Virology|October 9, 2009
Identification of hepatitis C virus NS5A inhibitorsJulie A Lemm, Donald O'Boyle, Mengping Liu, et al.
The Journal of General Virology|July 29, 2011
The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localizationDike Qiu, Julie A Lemm, Donald R O'Boyle, et al.
Molecular Cancer Therapeutics|December 13, 2024
Preclinical Evaluation of Bavdegalutamide (ARV-110), a Novel PROteolysis TArgeting Chimera Androgen Receptor DegraderLawrence B Snyder, Taavi K Neklesa, Ryan R Willard, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2011
Discovery of potent hepatitis C virus NS5A inhibitors with dimeric structuresJulie A Lemm, John E Leet, Donald R O'Boyle, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical StilbenesJeffrey L Romine, Denis R St Laurent, John E Leet, et al.
Pageof 3